Investments
11Portfolio Exits
2About Skyviews Life Science
Skyviews Life Science is specifically designed to identify investment opportunities in companies at the growing interface between biotechnology, molecular nutrition and digital platforms that prevent the onset and facilitate the management of chronic conditions.
Skyviews Life Science Headquarter Location
United States
Latest Skyviews Life Science News
Apr 15, 2022
BDC Bioscience, a Davis, CA-based biotechnology company, raised USD 12M in Series A funding. The round was led by Acre Venture Partners, with participation from Seventure Partners iSelect Fund, Collaborative Fund and Skyviews Life Science.
Skyviews Life Science Investments
11 Investments
Skyviews Life Science has made 11 investments. Their latest investment was in Tropic Biosciences as part of their Series C on July 7, 2022.
Skyviews Life Science Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
7/6/2022 | Series C | Tropic Biosciences | $35M | No | 3 | |
3/11/2022 | Series A - II | BCD Bioscience | $12M | Yes | 3 | |
7/21/2021 | Series D | Vedanta Biosciences | $68M | Yes | 23 | |
7/7/2021 | Series B | |||||
5/5/2021 | Series B |
Date | 7/6/2022 | 3/11/2022 | 7/21/2021 | 7/7/2021 | 5/5/2021 |
|---|---|---|---|---|---|
Round | Series C | Series A - II | Series D | Series B | Series B |
Company | Tropic Biosciences | BCD Bioscience | Vedanta Biosciences | ||
Amount | $35M | $12M | $68M | ||
New? | No | Yes | Yes | ||
Co-Investors | |||||
Sources | 3 | 3 | 23 |
Skyviews Life Science Portfolio Exits
2 Portfolio Exits
Skyviews Life Science has 2 portfolio exits. Their latest portfolio exit was MaaT Pharma on November 03, 2021.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
11/3/2021 | IPO | Public | 2 | ||
Date | 11/3/2021 | |
|---|---|---|
Exit | IPO | |
Companies | ||
Valuation | ||
Acquirer | Public | |
Sources | 2 |
Skyviews Life Science Team
1 Team Member
Skyviews Life Science has 1 team member, including current Chief Executive Officer, Managing Partner, Stefan Catsicas.
Name | Work History | Title | Status |
|---|---|---|---|
Stefan Catsicas | Nestle, King Abdullah University of Science and Technology, Ecole Polytechnique Federale de Lausanne, Université de Lausanne, GSK, and Scripps Research Institute | Chief Executive Officer, Managing Partner | Current |
Name | Stefan Catsicas |
|---|---|
Work History | Nestle, King Abdullah University of Science and Technology, Ecole Polytechnique Federale de Lausanne, Université de Lausanne, GSK, and Scripps Research Institute |
Title | Chief Executive Officer, Managing Partner |
Status | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.